Why do COX-2 inhibitors increase risk of cardiovascular events?

This article nicely reviews potential mechanisms for the increase in cardiovascular events seen with higher frequency in users of these new “superdrugs.” Millions spent developing and advertising for the superior safety profile of Celebrex and Vioxx–only to find an increasing risk of other types of conditions. This is the perfect example of the true guinea pigs of new drugs–the patients taking a new drug for the first decade or so of its use. When a new drug hits the open market this is the first time that particular drug has been used on such a large study and this is when the dangerous side effects often first appear.

The Journal : Current Issue –

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.